Avecho Biotechnology
- Biotech or pharma, animal health
- Biotech or pharma, therapeutic R&D
Avecho is a clinical-stage Biotechnology company developing novel drug products with increased absorption. Products are differentiated using TPM, a proprietary excipient used to increase drug solubility and/or absorption. Avecho's lead asset is a pharmaceutical cannabidiol product currently in a pivotal Phase III clinical trial for insomnia. The Australian rights to this product were recently licensed to Sandoz AG.
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}